References
- World Federation for Mental Health (WFMH). Depression: a global crisis. World Ment Heal Day. 2012:32.
- McGrath PJ, Stewart JW, Fava M. Tranylcypromine versus venlafaxine plus mirtazapine following three failed antidepressant medication trials for depression: a STAR*D report. AJP. 2006;163:1531–1541.
- Mann JJ, Aarons SF, Wilner PJ, et al. A controlled study of the antidepressant efficacy and side effects of (−)-deprenyl: a selective monoamine oxidase inhibitor. Arch Gen Psychiatry. 1989;46:45–50.
- McGrath PJ, Stewart JW, Harrison W, et al. A placebo-controlled trial of l-deprenyl in atypical depression. Psychopharmacol Bull. 1989;25:63–67.
- Sunderland T, Cohen RM, Molchan S, et al. High-dose selegiline in treatment-resistant older depressive patients. Arch Gen Psychiatry. 1994;51:607–615.
- Moschwitzer J, Achleitner G, Pomper H, et al. Development of an intravenously injectable chemically stable aqueous omeprazole formulation using nanosuspension technology. Eur J Pharm Biopharm. 2004;58:615–619.
- Francis D, Mouftah S, Steffen R, et al. Ion milling coupled field emission scanning electron microscopy reveals current misunderstanding of morphology of polymeric nanoparticles. Eur J Pharm Biopharm. 2015;89:56–61.
- Dong C, Chen W, Liu C, et al. Synthesis of magnetic chitosan nanoparticle and its adsorption property for humic acid from aqueous solution. Colloids Surf A. 2014;446:179–189.
- Xu Q, Kambhampati SP, Kannan RM, et al. Nanotechnology approaches for ocular drug delivery. Middle East Afr J Ophthalmol. 2013;20:26–37.
- Willcox MDP. Characterization of the normal microbiota of the ocular surface. Exp Eye Res. 2013;117:99–105.
- Tian B-C, Zhang W-J, Xu H-M, et al. Further investigation of nanostructured lipid carriers as an ocular delivery system: in vivo transcorneal mechanism and in vitro release study. Colloids Surf B Biointerfaces. 2013;102:251–256.
- Ustundag-Okur N, Gokce EH, Bozbiyik DI, et al. Preparation and in vitro–in vivo evaluation of ofloxacin loaded ophthalmic nanostructured lipid carriers modified with chitosan oligosaccharide lactate for the treatment of bacterial keratitis. Eur J Pharm Sci. 2014;63:204–215.
- Lee VHL, Robinson JR. topical ocular drug delivery: recent developments and future challenges. J Ocul Pharmacol. 1986;2:67–108.
- Madhav NVS, Yadav AP. A novel translabial platform utilizing bioexcipients from Litchi chinesis for the delivery of rosiglitazone maleate. Acta Pharm Sin B. 2013;3:408–415.
- Madhav NVS, Raina D. Formulation and performance evaluation of Escitalopram loaded bionanosuspension using a novel bio-retardant from Piper nigrum. Int J Life Sci Rev. 2017;5:60–66.
- Kotecha RK, Bhadra S, Rajesh KS. Formulation & process development of azithromycin ophthalmic nanosuspension. Int J Pharm Pharm Sci. 2013;4:490–497.
- Dattatraya SM, Loknete JD. Formulation and in vitro evaluation of fast dissolving tablet of verapamil hydrochloride. Int J Pharm Pharm Sci. 2018;10:93–99.
- Varshney S, Madhav N. Design evaluation of bio-flexy films using a novel biopolymer from Manilkara zapota loaded with nanosized Tiagabine. Egypt Pharm J. 2017;2:1–6.